Serum BAFF expression in patients with myasthenia gravis
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Jee Young | - |
dc.contributor.author | Yang, Young | - |
dc.contributor.author | Moon, Joon-Shik | - |
dc.contributor.author | Lee, Eun Young | - |
dc.contributor.author | So, Sun Hwha | - |
dc.contributor.author | Lee, Hong-Soo | - |
dc.contributor.author | Park, Kee Duk | - |
dc.contributor.author | Choi, Young-Chul | - |
dc.date.available | 2021-02-22T14:33:15Z | - |
dc.date.issued | 2008-08 | - |
dc.identifier.issn | 0165-5728 | - |
dc.identifier.issn | 1872-8421 | - |
dc.identifier.uri | https://scholarworks.sookmyung.ac.kr/handle/2020.sw.sookmyung/14208 | - |
dc.description.abstract | A B-cell activating factor of the tumor necrosis factor (TNF) family (BAFF) is an essential B-cell survival factor. Myasthenia gravis (MG) is one of the most typical antibody-mediated autoimmune disorders. To test whether serum BAFF levels are increased in MG patients, we compared the serum BAFF levels of 40 MG patients with those of 30 healthy controls. Serum BAFF levels of MG group Were significantly higher than those of healthy group. These results suggested that the BAFF might play a role in the immunopathogenesis of MG and further study on B-cell and T-cell activation may be needed. (C) 2008 Elsevier B.V. All rights reserved. | - |
dc.format.extent | 4 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | ELSEVIER SCIENCE BV | - |
dc.title | Serum BAFF expression in patients with myasthenia gravis | - |
dc.type | Article | - |
dc.publisher.location | 네델란드 | - |
dc.identifier.doi | 10.1016/j.jneuroim.2008.05.010 | - |
dc.identifier.scopusid | 2-s2.0-47549101395 | - |
dc.identifier.wosid | 000258892200018 | - |
dc.identifier.bibliographicCitation | JOURNAL OF NEUROIMMUNOLOGY, v.199, no.1-2, pp 151 - 154 | - |
dc.citation.title | JOURNAL OF NEUROIMMUNOLOGY | - |
dc.citation.volume | 199 | - |
dc.citation.number | 1-2 | - |
dc.citation.startPage | 151 | - |
dc.citation.endPage | 154 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Immunology | - |
dc.relation.journalResearchArea | Neurosciences & Neurology | - |
dc.relation.journalWebOfScienceCategory | Immunology | - |
dc.relation.journalWebOfScienceCategory | Neurosciences | - |
dc.subject.keywordPlus | B-LYMPHOCYTE STIMULATOR | - |
dc.subject.keywordPlus | MULTIPLE-SCLEROSIS | - |
dc.subject.keywordPlus | RECEPTORS | - |
dc.subject.keywordPlus | APRIL | - |
dc.subject.keywordAuthor | BAFF | - |
dc.subject.keywordAuthor | B lymphocyte stimulator | - |
dc.subject.keywordAuthor | myasthenia gravis (MG) | - |
dc.identifier.url | https://www.jni-journal.com/article/S0165-5728(08)00174-4/fulltext | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Sookmyung Women's University. Cheongpa-ro 47-gil 100 (Cheongpa-dong 2ga), Yongsan-gu, Seoul, 04310, Korea02-710-9127
Copyright©Sookmyung Women's University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.